Literature DB >> 23345154

Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.

Yoshiki Kozu1, Mitsuhiro Isaka, Yasuhisa Ohde, Kengo Takeuchi, Takashi Nakajima.   

Abstract

A 57-year-old Japanese man presented with massive right pleural effusion, and a huge tumor arising in the pleural cavity was detected by chest computed tomography. A thoracoscopic tumor biopsy revealed that the tumor protruded extensively into the pleural cavity, and its gross appearance was cystic and glossy. Microscopically, the tumor cells were rounded and epithelioid in shape. Prominent and abundant myxoid stroma was also present together with an inflammatory infiltrate, and the tumor was anaplastic lymphoma kinase (ALK)-immunopositive. Fluorescence in situ hybridization revealed that the Ran-binding protein 2-ALK fusion gene was present. Taken together, these findings supported the diagnosis of epithelioid inflammatory myofibroblastic sarcoma (EIMS), which is a variant of an inflammatory myofibrobrastic tumor. This is the first reported case of an EIMS arising in the pleural cavity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345154     DOI: 10.1007/s11748-013-0204-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  7 in total

1.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Authors:  James E Butrynski; David R D'Adamo; Jason L Hornick; Paola Dal Cin; Cristina R Antonescu; Suresh C Jhanwar; Marc Ladanyi; Marzia Capelletti; Scott J Rodig; Nikhil Ramaiya; Eunice L Kwak; Jeffrey W Clark; Keith D Wilner; James G Christensen; Pasi A Jänne; Robert G Maki; George D Demetri; Geoffrey I Shapiro
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

2.  Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.

Authors:  Adrián Mariño-Enríquez; Wei-Lien Wang; Angshumoy Roy; Dolores Lopez-Terrada; Alexander J F Lazar; Christopher D M Fletcher; Cheryl M Coffin; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

3.  Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.

Authors:  Zhigui Ma; D Ashley Hill; Margaret H Collins; Stephan W Morris; Janos Sumegi; Ming Zhou; Craig Zuppan; Julia A Bridge
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

4.  Complete resection of pulmonary inflammatory pseudotumors has excellent long-term prognosis.

Authors:  Dominique Fabre; Elie Fadel; Sunil Singhal; Vincent de Montpreville; Sacha Mussot; Olaf Mercier; Olivier Chataigner; Philippe G Dartevelle
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-19       Impact factor: 5.209

5.  An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.

Authors:  Sung-Ting Chen; Jen-Chieh Lee
Journal:  Hum Pathol       Date:  2008-08-12       Impact factor: 3.466

6.  RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.

Authors:  Ankita S Patel; Kathleen M Murphy; Anita L Hawkins; Julie S Cohen; Patricia P Long; Elizabeth J Perlman; Constance A Griffin
Journal:  Cancer Genet Cytogenet       Date:  2007-07-15

7.  Inflammatory myofibroblastic tumor of the lung.

Authors:  Hiroyuki Sakurai; Tadashi Hasegawa; Shun ichi Watanabe; Kenji Suzuki; Hisao Asamura; Ryosuke Tsuchiya
Journal:  Eur J Cardiothorac Surg       Date:  2004-02       Impact factor: 4.191

  7 in total
  18 in total

Review 1.  ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Authors:  Kana Sakamoto; Hideki Nakasone; Yuki Togashi; Seiji Sakata; Naoko Tsuyama; Satoko Baba; Akito Dobashi; Reimi Asaka; Chien-Chen Tsai; Shih-Sung Chuang; Koji Izutsu; Yoshinobu Kanda; Kengo Takeuchi
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

2.  Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Xuemei Du; Ying Gao; Hongyu Zhao; Bin Li; Weimin Xue; Daye Wang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

3.  Epithelioid inflammatory myofibroblastic sarcoma: a case report.

Authors:  Daniel E Sarmiento; Jessica A Clevenger; Gregory A Masters; Thomas L Bauer; Brian T Nam
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

4.  Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement with bland cytological features mimicking desmoid-type fibromatosis: A case report and review of the literature.

Authors:  Yu-Hua Huang; Yu-Feng Tian; Chien-Feng Li
Journal:  Oncol Lett       Date:  2016-01-07       Impact factor: 2.967

Review 5.  Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.

Authors:  Hui Wu; Yu-Hong Meng; Ping Lu; Hao-Yong Ning; Liu Hong; Xiao-Ling Kang; Min-Gang Duan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm.

Authors:  Jun Zhou; Guozhong Jiang; Dandan Zhang; Lan Zhang; Jingjing Xu; Shenglei Li; Wencai Li; Yihui Ma; Ahong Zhao; Zhihua Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 7.  Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.

Authors:  Shefali Chopra; Nolan Maloney; Wei Lien Wang
Journal:  Brain Tumor Pathol       Date:  2021-11-06       Impact factor: 3.298

8.  Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.

Authors:  Priyanka Singh; Aruna Nambirajan; Manish Kumar Gaur; Rahul Raj; Sunil Kumar; Prabhat Singh Malik; Deepali Jain
Journal:  J Pathol Transl Med       Date:  2022-07-07

Review 9.  Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.

Authors:  Qiuyu Liu; Yunzhen Kan; Yuewu Zhao; Hui He; Lingfei Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 10.  Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.

Authors:  Xinge Fu; Juhong Jiang; Xiao-ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.